Nl-Fr

View abstract

TitleEnzymatic vitreolysis with µplasmin: a new tool in the vitreoretinal surgery?
Abstract Nr.131
PurposeSeveral vitreoretinal diseases are caused or enhanced by traction of the posterior vitreous membrane on the macular area, such as: vitreomacular traction syndrome, idiopathic macular hole formation, diabetic retinopathy and even age related macular degeneration.
At present, several clinical studies are being performed to evaluate the safety and efficacy of microplasmin to induce a posterior vitreous detachment, avoiding the need to perform a vitrectomy in these patients.
MethodsPatients are randomized to different doses of microplasmin intravitreal injection or a placebo injection (not administered intravitreally).
Vitreomacular traction is evaluated at baseline and at several timepoints after administration of the study drug by a masked observer using slit lamp examination, ophthalmoscopy, optical coherence tomography (OCT) and B-scan ultrasound.
ResultsAt present, injection of microplasmin intravitreally is well tolerated, and is capable of inducing a posterior vitreous detachment in several included patients.
ConclusionAlthough clinical studies are far from completed, it seems that microplasmin may become a valuable tool for the vitreoretinal specialist in the treatment of several eye diseases related to vitreomacular traction.
Author 1
Last nameSTALMANS
InitialsP
DepartmentDept. Ophthalmology UZLeuven
CityLeuven
Author 2
Last nameVAN CALSTER
InitialsJ
DepartmentDept. Ophthalmology UZLeuven
CityLeuven
Author 3
Last nameVAN AKEN
InitialsE
DepartmentUZGent
CityGent
Author 4
Last nameDELAEY
InitialsC
DepartmentUZGent
CityGent
Author 5
Last nameDE SMET
InitialsMD
DepartmentMiddelheim Hospital
CityAntwerp
top ^